deltatrials
Completed PHASE2 INTERVENTIONAL 1-arm NCT03045328

Venetoclax and Ibrutinib in Patients With Relapsed/Refractory CLL or SLL

An Open Label Phase 2 Trial of Venetoclax With Ibrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma

Sponsor: Steven E. Coutre

Conditions Recurrent Chronic Lymphocytic Leukemia Recurrent Small Lymphocytic Lymphoma Refractory Chronic Lymphocytic Leukemia Refractory Small Lymphocytic Lymphoma
Interventions Ibrutinib Venetoclax
Updated 10 times since 2017 Last updated: Sep 1, 2021 Started: Sep 26, 2017 Primary completion: May 19, 2020 Completion: Aug 5, 2021
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Recurrent Chronic Lymphocytic Leukemia and Recurrent Small Lymphocytic Lymphoma, this trial is completed. The trial is conducted by Steven E. Coutre and has accumulated 10 data snapshots since 2017. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

~Feb 2017 – ~Oct 2017 · 8 months · monthly snapshotNot Yet Recruiting~Oct 2017 – ~Jun 2018 · 8 months · monthly snapshotRecruiting~Jun 2018 – ~Mar 2019 · 9 months · monthly snapshotRecruiting~Mar 2019 – ~Aug 2019 · 5 months · monthly snapshotRecruiting~Aug 2019 – ~Aug 2020 · 12 months · monthly snapshotActive Not Recruiting~Aug 2020 – ~Jan 2021 · 5 months · monthly snapshotActive Not Recruiting~Jan 2021 – ~Oct 2021 · 9 months · monthly snapshotActive Not Recruiting~Oct 2021 – ~Jul 2024 · 33 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 21 months · monthly snapshotCompleted

Change History

10 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  3. Oct 2021 — Jul 2024 [monthly]

    Completed PHASE2

    Status: Active Not Recruiting → Completed

  4. Jan 2021 — Oct 2021 [monthly]

    Active Not Recruiting PHASE2

  5. Aug 2020 — Jan 2021 [monthly]

    Active Not Recruiting PHASE2

▶ Show 5 earlier versions

  1. Aug 2019 — Aug 2020 [monthly]

    Active Not Recruiting PHASE2

    Status: Recruiting → Active Not Recruiting

  2. Mar 2019 — Aug 2019 [monthly]

    Recruiting PHASE2

  3. Jun 2018 — Mar 2019 [monthly]

    Recruiting PHASE2

  4. Oct 2017 — Jun 2018 [monthly]

    Recruiting PHASE2

    Status: Not Yet Recruiting → Recruiting · Phase: PHASE1_PHASE2 → PHASE2

  5. Feb 2017 — Oct 2017 [monthly]

    Not Yet Recruiting PHASE1_PHASE2

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Steven E. Coutre
Data source: Stanford University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations